Anthem Blue Cross Blue Shield of Colorado prior authorization, page 70

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
J1439Injection, ferric carboxymaltose, 1mgColorado Prior Authorization List, Pg 156 Original policy
J1440Fecal microbiota, live - jslm, 1 mlColorado Prior Authorization List, Pg 156 Original policy
J14425G-CSFexcludes biosimilars, 1 microgramColorado Prior Authorization List, Pg 156 Original policy
J1447Injection, tbo-filgrastim, 1 microgramColorado Prior Authorization List, Pg 156 Original policy
J1448Injection, trilaciclib, 1 mgColorado Prior Authorization List, Pg 156 Original policy
J1449Injection, eflapegrastim-xnst, 0.1 mgColorado Prior Authorization List, Pg 156 Original policy
J1450FluconazoleColorado Prior Authorization List, Pg 156 Original policy
J1454Injection, fosnetupitant 235 mg and palonosetron 0.25 mgColorado Prior Authorization List, Pg 156 Original policy
J1458INJECTION, GALSULFASE, 1 MGColorado Prior Authorization List, Pg 156 Original policy
J1459Injection, immune globulin (Privigen), intravenous, nonlyophilized (e.g., liquid), 500 mgColorado Prior Authorization List, Pg 156 Original policy
J1460Gamma Globulin 1 Cc InjColorado Prior Authorization List, Pg 156 Original policy
J1551Injection, immune globulin (cutaquig), 100 mgColorado Prior Authorization List, Pg 156 Original policy
J1552Injection, immune globulin (alyglo), 500 mgColorado Prior Authorization List, Pg 156 Original policy
J1554Injection, immune globulin (asceniv), 500 mgColorado Prior Authorization List, Pg 156 Original policy
J1555Injection, immune globulin (Cuvitru), 100 mgColorado Prior Authorization List, Pg 156 Original policy
J1556Injection, immune globulin (bivigam), 500 mgColorado Prior Authorization List, Pg 156 Original policy
J1557Injection, immune globulin, (Gammaplex), intravenous, nonlyophilized (e.g., liquid), 500 mgColorado Prior Authorization List, Pg 156 Original policy
J1558Injection, immune globulin (xembify), 100 mgColorado Prior Authorization List, Pg 156 Original policy
J1559Injection, immune globulin (hizentra), 100 mgColorado Prior Authorization List, Pg 156 Original policy
J1560Gamma Globulin > 10 Cc InjColorado Prior Authorization List, Pg 156 Original policy
J1561Injection, immune globulin, (Gamunex/Gamunex-C/Gammaked), nonlyophilized (e.g., liquid), 500 mgColorado Prior Authorization List, Pg 156 Original policy
J1565Rsv-IvigColorado Prior Authorization List, Pg 156 Original policy
J1566Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mgColorado Prior Authorization List, Pg 156 Original policy
J1568Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g.Colorado Prior Authorization List, Pg 156 Original policy
J1569Injection, immune globulin, (gammagard liquid/gammagard liquid erc), 500 mgColorado Prior Authorization List, Pg 156 Original policy
J1572Injection, immune globulin, (Flebogamma/Flebogamma Dif), intravenous, nonlyophilized (e.g., liquid), 500 mgColorado Prior Authorization List, Pg 156 Original policy
J1575Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulinColorado Prior Authorization List, Pg 157 Original policy
J1576Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mgColorado Prior Authorization List, Pg 157 Original policy
J1595Injection, glatiramer acetate, 20 mgColorado Prior Authorization List, Pg 157 Original policy
J1599Injection, immune globulin, intravenous, non-lyophilized (e.g. liquid), not otherwise specified, 500 mgColorado Prior Authorization List, Pg 157 Original policy
J1602Injection, golimumab, 1 mg, for intravenous useColorado Prior Authorization List, Pg 157 Original policy
J1628Injection, guselkumab, 1 mgColorado Prior Authorization List, Pg 157 Original policy
J1632Injection, brexanolone, 1 mgColorado Prior Authorization List, Pg 157 Original policy
J1743Injection, idursulfase, 1 mgColorado Prior Authorization List, Pg 157 Original policy
J1744Injection, icatibant, 1 mgColorado Prior Authorization List, Pg 157 Original policy
J1745Injection, infliximab, excludes biosimilar, 10 mgColorado Prior Authorization List, Pg 157 Original policy
J1746Injection, ibalizumab-uiyk, 10 mgColorado Prior Authorization List, Pg 157 Original policy
J1747Injection, spesolimab-sbzo, 1 mgColorado Prior Authorization List, Pg 157 Original policy
J1748Injection, infliximab-dyyb (Zymfentra), 10 mgColorado Prior Authorization List, Pg 157 Original policy
J1786Injection, imiglucerase, 10 unitsColorado Prior Authorization List, Pg 157 Original policy
J1809Injection, fosdenopterin, 0.1 mgColorado Prior Authorization List, Pg 157 Original policy
J1823Injection, inebilizumab-cdon, 1 mgColorado Prior Authorization List, Pg 157 Original policy
J1826Injection, interferon beta-1a, 30 mcgColorado Prior Authorization List, Pg 157 Original policy
J1830Interferon Beta-1b / .25 MgColorado Prior Authorization List, Pg 157 Original policy
J1930Injection, lanreotide, 1 mgColorado Prior Authorization List, Pg 157 Original policy
J1931Laronidase injectionColorado Prior Authorization List, Pg 157 Original policy
J1932Injection, lanreotide, (cipla), 1 mgColorado Prior Authorization List, Pg 157 Original policy
J1950Leuprolide Acetate /3.75 MgColorado Prior Authorization List, Pg 157 Original policy
J1951Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mColorado Prior Authorization List, Pg 157 Original policy
J1954Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mgColorado Prior Authorization List, Pg 157 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.